Marijuana regulators in Washington State are moving forward with creating a process to allow marijuana businesses to document their participation in the medical cannabis market in order to ease their access to benefits that come with the Trump administration’s partial rescheduling move.
Under an order issued by Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA).
While an administrative hearing is considering broader marijuana rescheduling, Washington businesses in the meantime have no way to verify their medical cannabis-specific activities, and state Liquor and Cannabis Board (LCB) officials said in June that rescheduling cannabis on the federal level “does not appear to apply” to businesses in Washington.
But LCB on Wednesday unanimously voted to accept a rulemaking petition from The Cannabis Alliance and Caitlein Ryan that seeks to create a process allowing marijuana businesses to “request verification of their regulatory status and activities authorized under [medical cannabis laws] for use in governmental, regulatory, financial, research, insurance, litigation, or other lawful purposes, including federal registration processes.”
The board’s
Read full article on Marijuana Moment
